Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome. Millefiorini E, Gasperini C, Pozzilli C, D'Andrea F, Bastianello S, Trojano M, Morino S, Morra VB, Bozzao A, Calo' A, et al. J Neurol. 1997 Mar; 244(3):153-9. PMID: 9050955. Abstract CommentRecommendBookmarkWatch